SIG — Sigma Healthcare Income Statement
0.000.00%
Last trade - 00:00
- AU$1.87bn
- AU$2.10bn
- AU$3.76bn
- 96
- 21
- 98
- 81
2020 January 31st | R2021 January 31st | C2022 January 31st | 2023 January 31st | 2024 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,344 | 3,509 | 3,549 | 3,762 | 3,417 |
Cost of Revenue | |||||
Gross Profit | 314 | 348 | 341 | 356 | 313 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,347 | 3,469 | 3,547 | 3,743 | 3,394 |
Operating Profit | -3.06 | 40 | 2.31 | 19.3 | 23.2 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -15.8 | 28.6 | -8.31 | 5.46 | 8.62 |
Provision for Income Taxes | |||||
Net Income After Taxes | -11.5 | 45 | -6.34 | 3.03 | 5.31 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -12.3 | 43.5 | -7.24 | 1.81 | 4.51 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.3 | 43.5 | -7.24 | 1.81 | 4.51 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.036 | 0.035 | -0.006 | 0.009 | 0.004 |
Dividends per Share |